Lafora disease is a rare, fatal genetic disorder affecting the brain, with limited treatment options and severe symptoms.

Scientists at Harvard University are proposing a fundamental change in the way we consider psychedelics and their therapeutic ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in ...

Women who’ve had a pregnancy loss can develop PMAD as well as ongoing trauma. Multiple losses put them at even higher risk.

For mothers, although postpartum depression and postpartum anxiety are receiving increased recognition, bipolar 1 disorder is ...

A group of Texas-based researchers has developed an effective way to treat post-traumatic stress disorder (PTSD) that ...

Learn about drug types, stages, administration routes, and molecular classifications. Explore therapies under development, emerging drugs, and key players like Sage Therapeutics and Relmada ...

Austin Clinical Trial Partners is one of approximately 70 research sites across the United States participating in a Phase 2 ...

A chemical first synthesized as a textiles dye in the 1800s is making the rounds on social media as an easy way to boost mood and enhance cognition. However, experts say it's only really useful in ...

What do we know about the ways major depressive disorder can affect comorbidities, and how does it affect treatment regimens?

The FDA has accepted the new drug application for the antipsychotic Bysanti and set a goal date for February 21, 2026.